April 02, 2026

CDC Lists Dozens of Infectious Disease Tests as Unavailable

More than two dozen assays paused or discontinued, with alternative testing options noted

Conexiant

March 30, 2026

UTI Prophylaxis Raises Resistance Risk

Study finds more resistance on culture, no significant rise in severe infections

Conexiant

March 23, 2026

Influencer Drug Promotion Raises Concerns

Study highlights regulatory gaps and persuasive risks in social media marketing

Conexiant

March 18, 2026

HPV Vaccine Delays Persist in Teens

Missed opportunities for HPV vaccination before sexual debut remain common, with practice variation and timing influencing uptake

Conexiant

March 17, 2026

Flu Vaccine Cut Hospitalizations Despite Drifted H3N2 Strain

Interim CDC estimates found the 2025–2026 vaccine reduced outpatient influenza visits by up to 41% and hospitalizations by up to 41%.

Conexiant

March 10, 2026

Study Maps US States Most Vulnerable to Flu

Machine learning analysis identifies 11 jurisdictions—including the District of Columbia, Massachusetts, and Hawaii—with the highest vulnerability to influenza-like illness.

Conexiant

March 09, 2026

Newborn Vitamin K Refusal Trends

Investigators examine trends in newborn vitamin K refusal and associated neurologic outcomes.

Conexiant

March 06, 2026

Framework Targets Hospital-Onset UTIs

The expert panel outlines surveillance, device management, and diagnostic stewardship strategies to address both catheter-associated and non–catheter-associated infections.

Conexiant

October 28, 2024

Single Swab Approach Assesses Co-Occurring Vaginal Infections

A recent study reveals that 80% of women with STIs may have bacterial vaginosis, highlighting the potential benefits of simultaneous STI and vaginitis testing in clinical practice.

Conexiant

November 22, 2024

FDA Official Expects Tightened Vaccine Review

"I don't necessarily view that as a bad thing."

Reuters